Objective Glenohumeral (GH) osteoarthritis (OA) is the third most common large joint disease, after hip and knee OA. This ...

The county’s internal auditor reported that in a sampling of contracts and expenditures paid for with American Rescue Plan ...

When people say "data is the new oil," they're usually referring to its value. But in reality, oil requires careful handling, management, ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.